DE69033560D1 - Arzneimittel für insulinresistente diabetiker - Google Patents

Arzneimittel für insulinresistente diabetiker

Info

Publication number
DE69033560D1
DE69033560D1 DE69033560T DE69033560T DE69033560D1 DE 69033560 D1 DE69033560 D1 DE 69033560D1 DE 69033560 T DE69033560 T DE 69033560T DE 69033560 T DE69033560 T DE 69033560T DE 69033560 D1 DE69033560 D1 DE 69033560D1
Authority
DE
Germany
Prior art keywords
insulin
medicinal products
dietary supplement
development
resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69033560T
Other languages
English (en)
Other versions
DE69033560T2 (de
Inventor
Joseph Larner
Allison Kennington
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Virginia UVA
Original Assignee
University of Virginia UVA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA filed Critical University of Virginia UVA
Publication of DE69033560D1 publication Critical patent/DE69033560D1/de
Application granted granted Critical
Publication of DE69033560T2 publication Critical patent/DE69033560T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69033560T 1989-03-08 1990-03-08 Arzneimittel für insulinresistente diabetiker Expired - Fee Related DE69033560T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32048289A 1989-03-08 1989-03-08
PCT/US1990/001109 WO1990010439A1 (en) 1989-03-08 1990-03-08 Dietary supplement for insulin-resistant diabetics

Publications (2)

Publication Number Publication Date
DE69033560D1 true DE69033560D1 (de) 2000-07-06
DE69033560T2 DE69033560T2 (de) 2001-03-01

Family

ID=23246630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69033560T Expired - Fee Related DE69033560T2 (de) 1989-03-08 1990-03-08 Arzneimittel für insulinresistente diabetiker

Country Status (10)

Country Link
US (1) US5124360A (de)
EP (1) EP0465508B1 (de)
JP (3) JPH04504847A (de)
AT (1) ATE193440T1 (de)
AU (1) AU647735B2 (de)
CA (1) CA2047686C (de)
DE (1) DE69033560T2 (de)
DK (1) DK0465508T3 (de)
ES (1) ES2146197T3 (de)
WO (1) WO1990010439A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
EP0568545A4 (en) * 1991-01-23 1993-11-24 The University Of Virginia Patents Foundation Method of reducing elevated blood sugar levels in humans
JPH0665080A (ja) * 1992-03-10 1994-03-08 Godo Shiyusei Kk α−グルコシダ−ゼ阻害剤を含有する、過血糖付随疾患の予防・治療剤、および保健食
US5420108A (en) * 1992-09-14 1995-05-30 Shohet; Isaac H. Method of controlling diabetes mellitus
TW282398B (de) * 1993-12-22 1996-08-01 Bristol Myers Squibb Co
US5652221A (en) * 1994-11-07 1997-07-29 The University Of Virginia Patent Foundation Method of treating defective glucose metabolism using synthetic insulin substances
US5550166A (en) * 1995-03-17 1996-08-27 Ostlund; Richard E. Pinitol and derivatives thereof for the treatment of metabolic disorders
US6086882A (en) 1997-08-06 2000-07-11 National Institute For Pharmaceutical Research Phytodrug for management of peptic ulcer and methods of preparing and using same
DE19707756A1 (de) * 1997-02-26 1998-08-27 Georgios Dr Pandalis Präparat auf der Basis von Kichererbsenpflanzen oder -pflanzenteilen
JP2001521551A (ja) * 1997-03-24 2001-11-06 ガルデルマ リサーチ アンド デヴェロップメント エス エヌ セ インスリン非依存性糖尿病の治療のためのレチノイド関連分子
CA2236641C (en) * 1997-05-07 2008-07-15 Cornell Research Foundation, Inc. Preparation of fagopyritols and uses therefor
US6492341B1 (en) 1997-05-07 2002-12-10 Cornell Research Foundation, Inc. Preparation of fagopyritols and uses therefor
US20010039297A1 (en) * 1998-05-19 2001-11-08 Insmed Pharmaceuticals, Inc. Compositions and method for improving insulin sensivity and glucose metabolism in individuals with impaired fasting glucose or impaired glucose tolerance
CA2374269C (en) 1999-05-20 2007-04-24 Humanetics Corporation Stimulating transport of glucose into animal tissue by the administration of pinitol
CZ20021346A3 (cs) * 1999-10-18 2003-06-18 Muscletech Research And Development Inc. Potravinový doplněk pro růst svalové hmoty a síly
US6784209B1 (en) * 1999-10-18 2004-08-31 Muscletech Research And Development Inc. Food supplement for increasing lean mass and strength
AU3982601A (en) * 2000-02-23 2001-09-03 Orentreich Foundation For The Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
KR20010091341A (ko) * 2000-03-14 2001-10-23 신용철 카이로이노시톨 추출물을 유효성분으로 함유하는 의약조성물
US6660891B2 (en) 2000-05-15 2003-12-09 Insmed Incorporated Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom
US6492339B1 (en) * 2001-05-23 2002-12-10 Insmed, Incorporated Compositions comprising D-chiro inositol and sulfonylureas and methods of treatment thereof
US6486127B1 (en) * 2001-05-23 2002-11-26 Insmed, Incorporated Compositions comprising D-chiro inositol and lipid lowering compounds and methods of treatment thereof
CA2483550C (en) 2002-05-09 2016-06-28 Cornell Research Foundation, Inc. Fagopyrum esculentum fagopyritol synthase gene and use thereof
US20060004096A1 (en) * 2004-05-28 2006-01-05 Joseph Larner Method of Treating Endothelial Dysfunction, Oxidative Stress and Related Diseases
US20060258754A1 (en) * 2004-05-28 2006-11-16 Joseph Larner Method of treating endothelial dysfunction, oxidative stress and related diseases
JP2007068476A (ja) * 2005-09-08 2007-03-22 Hokko Chem Ind Co Ltd 健康食品およびｄ−キロ−イノシトールを得る方法
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20090214474A1 (en) * 2006-11-01 2009-08-27 Barbara Brooke Jennings Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
AR074797A1 (es) * 2008-10-10 2011-02-16 Japan Tobacco Inc Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
SG11201809434YA (en) 2016-04-27 2018-11-29 Kobayashi Pharmaceutical Co Ltd Hair-growth agent
JP6838146B2 (ja) 2016-10-06 2021-03-03 ディーワイ ナチュラル カンパニー リミテッド ピニトール、ｄ−カイロ−イノシトール、又はこれらの類似化合物を有効成分として含む、女性の更年期症状の改善、予防、又は治療用の組成物
US11898184B2 (en) 2017-09-07 2024-02-13 Sweet Sense Inc. Low glycemic sugar composition
BR112020010343A2 (pt) 2017-11-23 2020-11-10 Biosearch, S.A. método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE464059C (sv) * 1988-09-15 1996-12-04 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
JPH03138126A (ja) * 1989-10-24 1991-06-12 Mitsubishi Gas Chem Co Inc 均一薄肉中空成形品の射出成形方法

Also Published As

Publication number Publication date
CA2047686A1 (en) 1990-09-09
EP0465508B1 (de) 2000-05-31
JP2002249427A (ja) 2002-09-06
CA2047686C (en) 2000-09-05
ATE193440T1 (de) 2000-06-15
WO1990010439A1 (en) 1990-09-20
EP0465508A1 (de) 1992-01-15
US5124360A (en) 1992-06-23
DK0465508T3 (da) 2000-08-07
DE69033560T2 (de) 2001-03-01
JP2000219624A (ja) 2000-08-08
ES2146197T3 (es) 2000-08-01
JPH04504847A (ja) 1992-08-27
AU5280890A (en) 1990-10-09
AU647735B2 (en) 1994-03-31
EP0465508A4 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
DE69033560T2 (de) Arzneimittel für insulinresistente diabetiker
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
Sullivan Jr et al. Acute carbamazepine toxicity resulting from overdose
Field et al. Effect of salicylate infusion on plasma-insulin and glucose tolerance in healthy persons and mild diabetics
Goodhart et al. The role of nutritional deficiencies in the production of cardiovascular disturbances in the alcohol addict
Craig et al. Infants, toddlers, and aspirin
Nayyar et al. Fixed drug eruption to oxyphenbutazone and phenylbutazone
Weller Neuropsychiatric symptoms following bismuth intoxication
Melander et al. Clinical pharmacology of glipizide
BEAN et al. Vitamin deficiencies in diarrheal states
Dodd et al. Fast atrial fibrillation induced by treatment of psoriasis with azathioprine.
Hultgren et al. Clinical and experimental study of use of khellin in treatment of angina pectoris
Silverstone Clinical use of appetite suppressants.
Kamimura Comparison of alpha-tocopheryl nicotinate and acetate on skin microcirculation
Rachmilewitz et al. The presence of electrocardiographic changes in nicotinic acid deficiency and their elimination by nicotinic acid
Begg Sulphaemoglobinaemia
Mandelbaum et al. Hypothyroidism, hyperlipemia and carotenemia
Rachmilewitz et al. Electrocardiographic changes and the effect of niacin therapy in pellagra
STRYKER et al. Determination of macrocytic anemia as an aid in diagnosis of certain deficiency dermatoses
von Delbruck et al. Tolerance studies with brotizolam in hospitalized patients.
JPS56108712A (en) Lecithin cholesterol acyl transferase activator
SU1701321A1 (ru) Гиполипидемическое антисклеротическое средство "Бензафлавин
Brown The effect of egg white and crystalline biotin methyl ester on a skin lesion in three infants
Wilhelmsen Beta-blockers and plasma triglycerides.
OSTRIC CLINICAL FEATURES OF AN EPIDEMIC OF VIRAL HEPATITIS IN BOSANSKA POSAVINA

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee